GE Healthcare Commercial Executive brings a breadth of experience in scientific instrumentation and global markets to drive North American presence

Borehamwood, UK, 01 June 2020: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety and scale-up, today announced the appointment of Mert Sahin Ph.D. as General Manager and Senior Vice President of H.E.L Inc., the Company’s North American subsidiary. He will lead a strong presence in North America, with a focus on customer-centered service and support.

Mert has a background in commercial leadership across the Life Sciences industry. He joins H.E.L from GE Healthcare where he held senior executive roles, most recently as Chief Marketing Officer for GE’s Medical Imaging business. During his time at GE, he held various roles across EMEA & North America within Healthcare, in particular Pharmaceuticals. Bioprocess and Medical Devices. Prior to GE, he held roles in the Life Sciences and Diagnostics industries. Originally from Turkey, Mert completed his Ph.D. at the University of Hamburg, Germany, and lived in multiple countries before relocating to Boston, MA in 2016.

Mert’s appointment follows other recent leadership team announcements at H.E.L across operational and commercial functions, in line with the Company’s strong growth and service support initiatives.

Louise Madden, CEO of H.E.L Group commented: “Despite these uncertain times, H.E.L recognizes the underlying strength of the North American market and the potential for significant growth. Mert will help us to build and deploy a stronger team across North America, to take advantage of this growth potential.  Mert is a decisive, highly action-oriented commercial leader, with a strong background in instrument sales and marketing.  As such, he will deliver results by focusing on the needs of our North American market and customers – helping them to unleash their full potential.”

Mert Sahin, General Manager and Senior Vice President of H.E.L Inc., said: “North America has always been one of the strongest markets for scientific equipment and consumables. Combine this with potential for continued growth throughout the chemical industry and it makes for an incredibly exciting time to be joining H.E.L Group. I look forward to working with Louise and my new colleagues to enhance our presence in North America and support our North American-based customers.”

Download Press Release as pdf

Notes to Editors

For further information, including high-resolution images, please contact:

Sarah Jeffery Zyme Communications
Tel: +44 (0)7771 730919

About H.E.L Group

H.E.L Group’s mission is to work together with chemistry, safety, and biotechnology experts to engineer and unleash the full potential of the scientific community. To this end, H.E.L develops and manufactures innovative scientific instruments and software designed to optimize the efficiency, safety, and productivity of key processes in chemistry and biology applications.
The H.E.L team of 70 includes highly skilled process and software engineers, based at their extensive research and manufacturing facilities in the UK, as well as sales and support offices around the world.H.E.L has a long history of solving complex challenges for customers. For more than 30 years the Company has worked with businesses and laboratories globally, providing proprietary automated solutions for the pharma, biotechnology, chemical, battery, and petrochemical sectors.
Following significant growth, and with annual revenues exceeding £10 million, the Company is extending the reach of its products to support and enable R&D and process optimization further across the US, China, and India.